Baricorcho
@Baricorcho
Since 1965. Observer. Medical Oncologist. Spanish Group for Breast Cancer Research (GEICAM). Álvaro Rodríguez-Lescure MD, PhD.
ID:531768328
21-03-2012 00:11:47
28,6K Tweets
3,8K Followers
1,3K Following
Follow People
Nice article in Journal of Clinical Oncology about current evidence and ongoing trials for optimizing post neoadjuvant treatment in EBC pts who get PCR.
Note that ctDNA based MRD has not yet proven to be beneficial for treatment decisions for EBC. We need better biomakers. Great article by 👍…
After her2 low , now it is turn of ER low . Should we treat ER low breast cancer as TNBC ? Excellent comment in The Lancet by Dr Helena Jernstrom and Dr Lisa Rayden 👏 . Should we give IO to ER low tumors like Tnbc ? Should we not give endocrine therapy to ER low tumors ?…
Likelihood of cytoreduction, low vs high , part of flow chart , seems to have typing error, high vs low. Low probability, should get NACT and high probability should get upfront surgery. ESMO - Eur. Oncology Dario Trapani
Paquetes del correo que llegan por sorpresa y te cambian el día. Siempre con mis Asturias pululando en mi mochila vital. Alimento para el cuerpo y para el alma, directo desde Oviedo. Gracias, Yolandina. Va a salir una fabada de órdago. Yolanda fernandez